The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

SPIRAPRILAT     (7S)-8-[(2S)-2-[[(1S)-1- carboxy-3-phenyl...

Synonyms: Spiraprilate, Spiraprilatum, CHEMBL579, SCH-33861, CHEBI:116952, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Sch 33861


High impact information on Sch 33861


Analytical, diagnostic and therapeutic context of Sch 33861


  1. Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension. Noble, S., Sorkin, E.M. Drugs (1995) [Pubmed]
  2. Pharmacokinetic-pharmacodynamic model relating spiraprilat plasma concentrations to systemic and regional hemodynamic effects in congestive heart failure. Bellissant, E., Chau, N.P., Thuillez, C., Gerbeau, C., Richard, C., Giudicelli, J.F. J. Cardiovasc. Pharmacol. (1997) [Pubmed]
  3. Pharmacokinetics and haemodynamic effects of a single oral dose of the novel ACE inhibitor spirapril in patients with chronic liver disease. Krähenbühl, S., Grass, P., Surve, A., Kutz, K., Reichen, J. Eur. J. Clin. Pharmacol. (1993) [Pubmed]
  4. Pharmacokinetics of spirapril and spiraprilat in patients with chronic renal failure. Stein, G., Sierakowski, B., Grass, P., Haufe, C.C., Jansa, U., Weidinger, G. Blood pressure. Supplement. (1994) [Pubmed]
  5. Angiotensin converting enzyme inhibitors: spirapril and related compounds. Smith, E.M., Swiss, G.F., Neustadt, B.R., McNamara, P., Gold, E.H., Sybertz, E.J., Baum, T. J. Med. Chem. (1989) [Pubmed]
  6. Effects of spiraprilat, an angiotensin-converting enzyme inhibitor, on anesthetized dogs in a new model of acute left ventricular failure. Nakazawa, M., Ishihara, T., Takahashi, Y., Okuhira, M., Imai, S. J. Cardiovasc. Pharmacol. (1993) [Pubmed]
  7. Hemodynamic and cardiac effects of spiraprilat in normal and sodium depleted conscious dogs. Gérard, J.L., Pussard, E., Berdeaux, A., Giudicelli, J.F. Fundamental & clinical pharmacology. (1990) [Pubmed]
  8. Pharmacokinetics of spirapril in renal impairment. Meredith, P.A., Grass, P., Guitard, C., Elliott, H.L. Blood pressure. Supplement. (1994) [Pubmed]
  9. Spirapril: pharmacokinetic properties and drug interactions. Grass, P., Gerbeau, C., Kutz, K. Blood pressure. Supplement. (1994) [Pubmed]
WikiGenes - Universities